Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes

Human Gene Therapy

Volumn 12, Issue 6, 2001, Pages 659-670

  Takahashi, S ^a   Rousseau, R F ^a   Yotnda, P ^a   Mei, Z ^a   Dotti, G ^a   Rill, D ^a   Hurwitz, R ^a   Marini, F ^b   Andreeff, M ^b   Brenner, M K ^a  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; INTEGRIN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS RECEPTOR; VIRUS VECTOR;

ADENOVIRUS; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; COXSACKIE VIRUS; EMBRYO; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

ADENOVIRIDAE; ANTIGEN-PRESENTING CELLS; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOTHERAPY; INTEGRINS; INTERFERON TYPE II; INTERLEUKIN-2; LEUKEMIA, B-CELL, CHRONIC; LUMINESCENT PROTEINS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; TRANSFECTION; TRANSGENES;

ADENOVIRIDAE; COXSACKIEVIRUS; COXSACKIEVIRUS B;

EID: 0035831627     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303401300057360     Document Type: Article

References (46)

1. Defective interleukin-2 production and responsiveness by T cells in patients with chronic lymphocytic leukemia of B cell variety
2. The CD40 antigen and its ligand
3. Adenovirus vectors for gene delivery
4. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5
5. CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: Stimulation of allogeneic versus autologous T cells generates different types of effector cells
6. Adenovirus vector infection of chronic lymphocytic leukemia B cells
7. Acquired CD40-ligand deficiency in chronic lymphocytic leukemia
8. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment
9. In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40
10. Characterization of the phytohemagglutinin-induced proliferating lymphocyte subpopulations in chronic lymphocytic leukemia patients using a clonogenic agar technique and monoclonal antibodies
11. Failure of B cells of chronic lymphocytic leukemia in presenting soluble and alloantigens
12. CD40 ligand induces an antileukemia immune response in vivo
13. A novel herpes vector for the high-efficiency transduction of normal and malignant human hematopoietic cells
14. CD40-CD40 ligand interactions stimulate B cell antigen processing
15. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response
16. Chronic lymphocytic leukaemia: Clonal origin in a committed B-lymphocyte progenitor
17. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors
18. Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: Evidence that normally released IL-2 is absorbed by the neoplastic B cell population
19. Immunoregulatory T-cell defects in B-cell chronic lymphocytic leukemia: Cause or consequence of the disease? The contributory role of decreased availability of interleukin 2 (IL-2)
20. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39
21. Immunobiology of chronic lymphocytic leukemia
22. Human CD40-ligand: Molecular cloning, cellular distribution and regulation of expression by factors controlling IgE production
23. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand
24. Lack of autologous mixed lymphocyte reaction in patients with chronic lymphocytic leukemia: Evidence for autoreactive T-cell dysfunction not correlated with phenotype, karyotype, or clinical status
25. Interferon-gamma upregulates the susceptibility of human neuroblastoma cells to interleukin-2 activated natural killer cells
26. Human adenovirus vectors for gene transfer into mammalian cells
27. A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses
28. Efficient adenovirus-mediated gene transduction of normal and leukemic hematopoietic cells
29. Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL
30. Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells
31. Serum levels of interleukin-10 in B-cell chronic lymphocytic leukemia
32. B-cell chronic lymphocytic leukaemia cells express and release transforming growth factor-beta
33. High-efficiency transduction of freshly isolated human tumor cells using adenoviral interleukin-2 vectors
34. Gene delivery to human B-precursor acute lymphoblastic leukemia cells
35. Adenovirus-mediated cytotoxicity of chronic lymphocytic leukemia cells
36. Tumorigenicity and immunogenicity of IFN-alpha and IL-2 gene-transfected tumor cells
37. Sensitivity and reproducibility in adenoviral infectious titer determination
38. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependant signal
39. Inherent inability of chronic lymphocytic leukaemia lymphocytes to respond to phytohaemagglutinin
40. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
41. Comparison of gene therapy with interleukin-2 gene modified fibroblasts and tumor cells in the murine CT-26 model of colorectal carcinoma
42. Interleukin-10 mRNA expression in B-cell chronic lymphocytic leukaemia inversely correlates with progression of disease
43. Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies
44. CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules
45. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment
46. T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity